01-Casebot-Excited

01-Casebot-Am I up for job?

1-CEO

1-CMO

1-CFO

1-COO

1-CIO

1-CIO-Encouraging results

1-CIO-what events?

1-COO-Someone outside

1-COO-Development?

1-SVPMarketing-Good News

1-SVPMarketing-So shocking

3-CEO-Prepublicity

3-CEO-Report Brenda

3-CEO-How this will affect

3-CEO-What to do

3-CEO-Goes to press

3-CEO-Talking her down

1-CFO-Waited till now

1-CFO-Communication strong

1-CEO-Be informed

1-CEO-Buck stops

1-CMO-Still stellar

1-CMO-There are protocols

2-CEO-Still disavow

3-CMO-Own the story

3-CMO-Revealed affair

3-CFO-Rational decision

3-CFO-Advances rebuffed

3-COO-Compromises integrity

3-COO-Relationship with CIO

3-CIO-Making advances

3-CIO-Reporting Brenda

4-CFO-Pros

4-CFO-Cons

4-CIO-How would you do that?

4-CIO-Sickle cell drug

4-CMO-Head down

4-CMO-Accelerating trials

4-COO-She'll leave

4-COO-Brilliant move

5-CEO-Not surprised

5-CEO-Confused

5-CFO-Let's hear it

5-CFO-Juvessence

5-CIO-Walter has his way

5-CIO-Managed buyout

5-CMO-Other options

5-CMO-Most keen

5-COO-Lead balloon

5-COO-What do you mean?

4-CEO-Are you in favor?

4-CEO-It's hard to think

2-CEO-Connect the dots

2-CEO-Makes no difference

2-CFO-One rumor

2-CFO-Now dying

2-CIO-If you'e that close

2-CIO-More than coincidence

2-CMO-I don't follow

2-CMO-I don't think

2-COO-Decisive action

2-COO-Laxness in lab

6-CEO-Get rid of

6-CEO-Major opportunities

6-CFO-Stock bump

6-CFO-Squelch innovation

6-CIO-Consider collaboration

6-CIO-Briliant, but...

6-CMO-Follow her lead

6-CMO-Dysfunctional atmosphere

6-COO-No brainer

6-COO-Free publicity

1-Observers

1-C-Suite-Executives

1-Non-CEO-C-Suite

PENDING

A measure of the growth or decline of the stock price that takes into account how a broad base of stakeholders view the future success of the company


Stock Market

A measure of how ready Xanformin would technically be able to be released to the market and fulfill its therapeutic mission

Xanformin Development

A measure of your support of your functional SVP.

Executive Support

Measures how group tasks, organizational structures and cultures are affected by, and affect, individuals’ experience at and of work. High scores mean individuals perceive the group dynamic and experience as being more effective while low scores reveal a perception of team dysfunction.

Team

Momo Saito is a performance coach who uses modern psychoanalysis in her work with the staff at Biolife. She focuses on the conscious and unconscious emotions that drive human behaviour, and the impact that feelings and group dynamics have on the decision-making process in high-pressure environments. 

Yes, it's wonderful news. Seems like Xanformin will be headed to clinical trials soon, which is incredibly exciting. If I'm not mistaken, scientist Brenda Latham is behind it. Can I speak to her? 

Since Xanformin is the reason for the stock jump, I'd love to speak to the scientist behind it about the timeline before launch. 

chat-image-0mnjxngafwgm.jpeg

Yes, I think her son died, unexpectedly. Tragic...

That's truly awful...But there must be someone carrying on her work that I can meet with, or at least the lab manager.

I did know about that terrible circumstance. However, I had also heard through the grapevine that her contract stipulated her return at three months.

https://vimeo.com/501825134/b1353491c6

Whoa...That was weird. First that Brenda is away past her contracted return. Then what's this about monkeys?

This doesn't look good. But we'll have to find out from  the lab whether this is just one trial group. Maybe it won't matter.

BioLife - Breaking News 1.mp4

Is that OK, Xavier, to look at our private Slack messages? That's a bit concerning. 

Wow, I'm psyched to find out more about these boundary pushing topics...but don't feel all that prepared given all that's been happening!

The BioLife Wicked Problems LiveCase creates a lively scenario in which to explore, examine and reflect on leadership and group dynamics under pressure. 

Leadership opportunity with the launch of a pioneering new drug.

Season 1

Season 2

Immersion into your roles as C-Suite Executives and Leadership Development Observers helping BioLife C-develop a new CRISPR-based anti-aging drug

Onboarding (individual)

Welcome to your first day! (individual)

You discover new information as you try to uncover the source of the issues.

What happened to the monkeys? (group)

The situation seems to be getting worse as you have to think about what to tell the press (if anything)

BioLife | Wicked Problems

Content

S1 Season 1

S2 Season 2